Home / Resource Library / Evaluation of second-generation Bruton’s tyrosine kinase inhibitors for the treatment of mantle cell lymphomaEvaluation of second-generation Bruton’s tyrosine kinase inhibitors for the treatment of mantle cell lymphoma